230 related articles for article (PubMed ID: 16170086)
1. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.
Kalkman JS; Schillings ML; van der Werf SP; Padberg GW; Zwarts MJ; van Engelen BG; Bleijenberg G
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1406-9. PubMed ID: 16170086
[TBL] [Abstract][Full Text] [Related]
2. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
[TBL] [Abstract][Full Text] [Related]
4. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
[TBL] [Abstract][Full Text] [Related]
5. Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.
Kalkman JS; Zwarts MJ; Schillings ML; van Engelen BG; Bleijenberg G
Neurol Sci; 2008 Sep; 29 Suppl 2():S238-40. PubMed ID: 18690504
[TBL] [Abstract][Full Text] [Related]
6. Experienced and physiological fatigue in neuromuscular disorders.
Schillings ML; Kalkman JS; Janssen HM; van Engelen BG; Bleijenberg G; Zwarts MJ
Clin Neurophysiol; 2007 Feb; 118(2):292-300. PubMed ID: 17166763
[TBL] [Abstract][Full Text] [Related]
7. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.
Smith AE; McMullen K; Jensen MP; Carter GT; Molton IR
Am J Phys Med Rehabil; 2014 May; 93(5):387-95. PubMed ID: 24247759
[TBL] [Abstract][Full Text] [Related]
8. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis.
Minis MA; Kalkman JS; Akkermans RP; Engels JA; Huijbregts PA; Bleijenberg G; Oostendorp RA; van Engelen BG
J Rehabil Med; 2010 Jan; 42(1):60-5. PubMed ID: 20111846
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of apathy in myotonic dystrophy type 1.
Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
[TBL] [Abstract][Full Text] [Related]
10. Is Going Beyond Rasch Analysis Necessary to Assess the Construct Validity of a Motor Function Scale?
Guillot T; Roche S; Rippert P; Hamroun D; Iwaz J; Ecochard R; Vuillerot C;
Arch Phys Med Rehabil; 2018 Sep; 99(9):1776-1782.e9. PubMed ID: 29625093
[TBL] [Abstract][Full Text] [Related]
11. The Dutch patients' perspective on oculopharyngeal muscular dystrophy: A questionnaire study on fatigue, pain and impairments.
van der Sluijs BM; Knoop H; Bleijenberg G; van Engelen BG; Voermans NC
Neuromuscul Disord; 2016 Mar; 26(3):221-6. PubMed ID: 26948710
[TBL] [Abstract][Full Text] [Related]
12. High disease impact of myotonic dystrophy type 2 on physical and mental functioning.
Tieleman AA; Jenks KM; Kalkman JS; Borm G; van Engelen BG
J Neurol; 2011 Oct; 258(10):1820-6. PubMed ID: 21461958
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of pain in fatigued patients with type 1 diabetes.
Menting J; Tack CJ; Knoop H
J Psychosom Res; 2017 Apr; 95():68-73. PubMed ID: 28314551
[TBL] [Abstract][Full Text] [Related]
14. Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.
Miró J; Gertz KJ; Carter GT; Jensen MP
Muscle Nerve; 2014 Jun; 49(6):900-5. PubMed ID: 24415580
[TBL] [Abstract][Full Text] [Related]
15. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
16. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects.
Lindeman E; Leffers P; Reulen J; Spaans F; Drukker J
Clin Rehabil; 1998 Apr; 12(2):127-35. PubMed ID: 9619654
[TBL] [Abstract][Full Text] [Related]
17. Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire.
Vandervelde L; Van den Bergh PY; Goemans N; Thonnard JL
Neuromuscul Disord; 2009 Feb; 19(2):99-103. PubMed ID: 19167889
[TBL] [Abstract][Full Text] [Related]
18. Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification Of Functioning, Disability and Health.
Kierkegaard M; Harms-Ringdahl K; Widén Holmqvist L; Tollbäck A
J Rehabil Med; 2009 Jun; 41(7):512-20. PubMed ID: 19543661
[TBL] [Abstract][Full Text] [Related]
19. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
20. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.
Wood L; Cordts I; Atalaia A; Marini-Bettolo C; Maddison P; Phillips M; Roberts M; Rogers M; Hammans S; Straub V; Petty R; Orrell R; Monckton DG; Nikolenko N; Jimenez-Moreno AC; Thompson R; Hilton-Jones D; Turner C; Lochmüller H
J Neurol; 2017 May; 264(5):979-988. PubMed ID: 28397002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
